Withdrawal seizures: possible risk factors

Area of Science:

• Neurology
• Clinical Pharmacology
• Epileptology

Background:

• Most patients achieve seizure freedom with antiseizure medications (ASMs).
• Discontinuing ASMs in seizure-free individuals presents significant management challenges.
• Balancing chronic treatment side effects against seizure relapse risk is critical.

Purpose of the Study:

• To review and discuss predictors and risk factors for seizure relapse during and after ASM discontinuation.
• To synthesize current literature evidence on factors influencing successful drug withdrawal.

Main Methods:

• Literature review of available evidence on ASM withdrawal.
• Analysis of risk factors and predictors for seizure relapse.
• Synthesis of expert opinion on decision-making and management strategies.

Main Results:

• Key risk factors for withdrawal failure include epilepsy etiology, persistent epileptiform EEG abnormalities, and brain MRI findings.
• Concurrent predictors must be considered collectively for accurate risk assessment.
• Individualized discontinuation programs are essential.

Conclusions:

• ASM withdrawal decisions require careful planning based on predictor evaluation.
• Discontinuation programs should involve patient/family discussions, individualized decisions, tailored taper schedules, and monitoring.
• A proactive approach to managing ASM withdrawal is vital for patient outcomes.